Literature DB >> 8500033

Guidelines for the identification, investigation and treatment of individuals with concomitant tuberculosis and HIV infection. Bureau of Communicable Disease Epidemiology, Canada Department of National Health and Welfare.

.   

Abstract

The following recommended guidelines, jointly prepared by the Canadian Thoracic Society, the Tuberculosis Directors of Canada, and the Department of National Health and Welfare in consultation with the provincial and territorial epidemiologists, AIDS coordinators and HIV caregivers, and approved by the Canadian Lung Association and the Canadian Thoracic Society are provided to assist health care workers who are caring for patients in the overlapping group.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8500033      PMCID: PMC1485852     

Source DB:  PubMed          Journal:  CMAJ        ISSN: 0820-3946            Impact factor:   8.262


  7 in total

1.  The booster phenomenon in serial tuberculin testing.

Authors:  N J Thompson; J L Glassroth; D E Snider; L S Farer
Journal:  Am Rev Respir Dis       Date:  1979-04

Review 2.  AIDS and the lung: update 1992. 2. Recent developments in the management of the pulmonary complications of HIV disease.

Authors:  D M Mitchell; R F Miller
Journal:  Thorax       Date:  1992-05       Impact factor: 9.139

3.  Spectrum of tuberculosis in patients with HIV infection in British Columbia: report of 40 cases.

Authors:  M Korzeniewska-Kosela; J M FitzGerald; S Vedal; E A Allen; M T Schechter; L Lawson; P Phillips; W Black; J S Montaner
Journal:  CMAJ       Date:  1992-06-01       Impact factor: 8.262

4.  Prevalence of tuberculin positivity and skin test anergy in HIV-1-seropositive and -seronegative intravenous drug users.

Authors:  N M Graham; K E Nelson; L Solomon; M Bonds; R T Rizzo; J Scavotto; J Astemborski; D Vlahov
Journal:  JAMA       Date:  1992-01-15       Impact factor: 56.272

Review 5.  Current tuberculosis treatment regimens. Choosing the right one for your patient.

Authors:  E J Pérez-Stable; P C Hopewell
Journal:  Clin Chest Med       Date:  1989-09       Impact factor: 2.878

Review 6.  Drug treatment of tuberculosis--1992.

Authors:  P T Davidson; H Q Le
Journal:  Drugs       Date:  1992-05       Impact factor: 9.546

7.  The chest roentgenogram in pulmonary tuberculosis patients seropositive for human immunodeficiency virus type 1.

Authors:  R Long; B Maycher; M Scalcini; J Manfreda
Journal:  Chest       Date:  1991-01       Impact factor: 9.410

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.